Literature DB >> 12745861

False-negative myocardial scintigraphy in balanced three-vessel disease, revealed by coronary pressure measurement.

Wilbert H Aarnoudse1, Kees-Joost B M Botman, Nico H J Pijls.   

Abstract

In nuclear perfusion imaging of the myocardium, a false-negative test result in patients with balanced three-vessel disease is a well-known pitfall. This paper describes a patient with typical chest pain and a negative myocardial perfusion scintigram. At coronary angiography, intermediate stenoses in the left anterior descending (LAD), left circumflex (LCX), and right coronary (RCA) arteries were present. Fractional flow reserve, measured by coronary pressure measurement, was 0.54, 0.56, and 0.66 respectively for the LAD, LCX, and RCA, unequivocally demonstrating the presence of balanced three-vessel disease. The patient underwent successful bypass surgery and remained event-free thereafter.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12745861     DOI: 10.1080/14628840310003244

Source DB:  PubMed          Journal:  Int J Cardiovasc Intervent        ISSN: 1462-8848


  22 in total

1.  Novel and simple carbon-11-labeled ammonium salts as PET agents for myocardial perfusion imaging.

Authors:  Ohad Ilovich; Hana Billauer; Sharon Dotan; Nanette M T Freedman; Moshe Bocher; Eyal Mishani
Journal:  Mol Imaging Biol       Date:  2011-02       Impact factor: 3.488

2.  Is it possible for myocardial perfusion imaging to avoid missing any patients with high-risk coronary disease?

Authors:  Mark I Travin
Journal:  J Nucl Cardiol       Date:  2007-07       Impact factor: 5.952

3.  Underestimation of extent of ischemia by gated SPECT myocardial perfusion imaging in patients with left main coronary artery disease.

Authors:  Daniel S Berman; Xingping Kang; Piotr J Slomka; James Gerlach; Ling de Yang; Sean W Hayes; John D Friedman; Louise E J Thomson; Guido Germano
Journal:  J Nucl Cardiol       Date:  2007-07       Impact factor: 5.952

Review 4.  Myocardial fractional flow reserve. Its role in guiding PCI in stable coronary artery disease.

Authors:  M Lindstaedt; A Mügge
Journal:  Herz       Date:  2011-08       Impact factor: 1.443

Review 5.  Present and future of clinical cardiovascular PET imaging in Europe--a position statement by the European Council of Nuclear Cardiology (ECNC).

Authors:  D Le Guludec; R Lautamäki; J Knuuti; J J Bax; F M Bengel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-06-26       Impact factor: 9.236

6.  Chest Pain with Normal Thallium-201 Myocardial Perfusion Image - Is It Really Normal?

Authors:  Pang-Yen Liu; Wen-Yu Lin; Li-Fan Lin; Chin-Sheng Lin; Wei-Shiang Lin; Shu-Meng Cheng; Shih-Ping Yang; Jun-Ting Liou
Journal:  Acta Cardiol Sin       Date:  2016-05       Impact factor: 2.672

7.  High-risk coronary artery disease, but normal myocardial perfusion: A matter of concern?

Authors:  Shu Yokota; Mohamed Mouden; Jan Paul Ottervanger
Journal:  J Nucl Cardiol       Date:  2015-05-21       Impact factor: 5.952

8.  Fractional flow reserve and myocardial viability as assessed by SPECT perfusion scintigraphy in patients with prior myocardial infarction.

Authors:  Branko Beleslin; Milan Dobric; Dragana Sobic-Saranovic; Vojislav Giga; Jelena Stepanovic; Ana Djordjevic-Dikic; Milan Nedeljkovic; Sinisa Stojkovic; Vladan Vukcevic; Goran Stankovic; Dejan Orlic; Zorica Petrasinovic; Smiljana Pavlovic; Vladimir Obradovic; Miodrag Ostojic
Journal:  J Nucl Cardiol       Date:  2010-06-04       Impact factor: 5.952

9.  A fast cardiac gamma camera with dynamic SPECT capabilities: design, system validation and future potential.

Authors:  Moshe Bocher; Ira M Blevis; Leonid Tsukerman; Yigal Shrem; Gil Kovalski; Lana Volokh
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-06-29       Impact factor: 9.236

10.  Prevalence, location, and extent of significant coronary artery disease in patients with normal myocardial perfusion imaging.

Authors:  Shu Yokota; Jan Paul Ottervanger; Mohamed Mouden; Jorik R Timmer; Siert Knollema; Pieter L Jager
Journal:  J Nucl Cardiol       Date:  2014-01-28       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.